Collegium Pharmaceutical
COLL
$36.42
Share price
1.62%
Change (1 day)
59.46%
Change (1 year)
Categories
EPS for Collegium Pharmaceutical (COLL)
EPS in 2023 (TTM): -$0.33
According to Collegium Pharmaceutical 's latest financial reports the company's current EPS (TTM) is -$0.33. In 2022 the company made an earnings per share (EPS) of -$0.74 a decrease over its 2021 EPS that were of $2.01.
EPS history for Collegium Pharmaceutical from 2014 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | -$0.33 | -55.41% |
| 2022 | -$0.74 | -136.82% |
| 2021 | $2.01 | 161.04% |
| 2020 | $0.77 | -213.24% |
| 2019 | -$0.68 | -43.33% |
| 2018 | -$1.20 | -51.61% |
| 2017 | -$2.48 | -36.08% |
| 2016 | -$3.88 | 139.48% |
| 2015 | -$1.62 | -42.94% |
| 2014 | -$2.84 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 United Therapeutics UTHR | $19.32 | -5,954.55% | 🇺🇸 USA |
 Agile Therapeutics
AGRX | -$39.56 | 11,887.88% | 🇺🇸 USA |
 Horizon Therapeutics
HZNP | $1.92 | -681.82% | 🇮🇪 Ireland |
 KemPharm KMPH | -$0.99 | 200.00% | 🇺🇸 USA |